Item Type | Name |
Academic Article
|
Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy.
|
Academic Article
|
CT-guided biopsy for the diagnosis of renal tumors before treatment with percutaneous ablation.
|
Academic Article
|
Male breast cancer during treatment with leuprolide for prostate cancer.
|
Academic Article
|
Masculinity and the body: how African American and White men experience cancer screening exams involving the rectum.
|
Academic Article
|
Men's knowledge and beliefs about prostate cancer: education, race, and screening status.
|
Academic Article
|
Radiofrequency ablation of renal tumors.
|
Academic Article
|
Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success.
|
Academic Article
|
The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function.
|
Academic Article
|
Dosimetric quantifiers for low-dose-rate prostate brachytherapy: is V(100) superior to D(90)?
|
Academic Article
|
A simple model predicts freedom from biochemical recurrence after low-dose rate prostate brachytherapy alone.
|
Academic Article
|
Microwave ablation of renal parenchymal tumors before nephrectomy: phase I study.
|
Academic Article
|
Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas.
|
Academic Article
|
Pretreatment prostate-specific antigen velocity is associated with freedom from biochemical recurrence of prostate cancer after low-dose-rate prostate brachytherapy alone.
|
Concept
|
Early Detection of Cancer
|
Concept
|
Urologic Neoplasms
|
Concept
|
Breast Neoplasms, Male
|
Concept
|
DNA, Neoplasm
|
Concept
|
Neuroectodermal Tumors
|
Concept
|
Neoplasms, Second Primary
|
Concept
|
Colorectal Neoplasms
|
Concept
|
Cancer Vaccines
|
Concept
|
Bone Neoplasms
|
Concept
|
Ureteral Neoplasms
|
Concept
|
Tumor Cells, Cultured
|
Concept
|
Lymphocytes, Tumor-Infiltrating
|
Concept
|
Bone Marrow Neoplasms
|
Concept
|
Neoplasm Recurrence, Local
|
Concept
|
American Cancer Society
|
Concept
|
RNA, Neoplasm
|
Concept
|
Neoplasm Invasiveness
|
Concept
|
Testicular Neoplasms
|
Concept
|
Neoplasms, Multiple Primary
|
Concept
|
Muscle Neoplasms
|
Concept
|
Tumor Burden
|
Concept
|
Lung Neoplasms
|
Concept
|
Wilms Tumor
|
Concept
|
Tumor Suppressor Protein p53
|
Concept
|
Prostatic Neoplasms
|
Concept
|
Neoplasm Metastasis
|
Concept
|
Genes, Tumor Suppressor
|
Concept
|
Urethral Neoplasms
|
Concept
|
Prostatic Intraepithelial Neoplasia
|
Concept
|
Urinary Bladder Neoplasms
|
Concept
|
Genes, Wilms Tumor
|
Concept
|
Neoplasm Proteins
|
Concept
|
Penile Neoplasms
|
Concept
|
Neoplasm Staging
|
Concept
|
Kidney Neoplasms
|
Concept
|
Endocrine Gland Neoplasms
|
Concept
|
Drug Resistance, Neoplasm
|
Concept
|
Neoplasm Transplantation
|
Concept
|
Von Hippel-Lindau Tumor Suppressor Protein
|
Concept
|
Neoplasms
|
Concept
|
Cell Line, Tumor
|
Concept
|
Tumor Suppressor Proteins
|
Academic Article
|
Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma.
|
Academic Article
|
DNA damage levels in prostate cancer cases and controls.
|
Academic Article
|
A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry.
|
Academic Article
|
GRade, Age, Nodes, and Tumor (GRANT) compared with Leibovich score to predict survival in localized renal cell carcinoma: A nationwide study.
|
Academic Article
|
Racial and Socioeconomic Disparities in MRI-Fusion Biopsy Utilization to Assess for Prostate Cancer.
|
Academic Article
|
Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I.
|
Academic Article
|
Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-up: AUA Guideline: Part II.
|
Academic Article
|
Racial Disparities in Prostate Specific Antigen Screening and Referral to Urology in a Large, Integrated Health Care System: A Retrospective Cohort Study.
|
Academic Article
|
Genomic analysis of response to bacillus Calmette-Guérin (BCG) treatment in high-grade stage 1 bladder cancer patients.
|
Academic Article
|
Diagnostic renal mass biopsy is associated with individual categories of PADUA and RENAL nephrometry scores: Analysis of diagnostic and concordance rates with surgical resection.
|
Academic Article
|
Differential effect of body mass index by gender on oncological outcomes in patients with renal cell carcinoma.
|
Academic Article
|
Claudin-2 inhibits renal clear cell carcinoma progression by inhibiting YAP-activation.
|
Academic Article
|
Identification of Genes Required for Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cells In Vitro.
|
Academic Article
|
Safety of decreasing ureteral stent duration following radical cystectomy.
|
Academic Article
|
Human epidermal growth factor receptor 2 overexpression is frequently discordant between primary and metastatic urothelial carcinoma and is associated with intratumoral human epidermal growth factor receptor 2 heterogeneity.
|
Academic Article
|
Epidemiology and survival outcome of adult kidney, bladder, and prostate rhabdomyosarcoma: A SEER database analysis.
|
Academic Article
|
Management changes for patients with endocrine-related cancers in the COVID-19 pandemic.
|
Academic Article
|
Increased nuclear factor I/B expression in prostate cancer correlates with AR expression.
|
Academic Article
|
Implementation of a Dedicated Enhanced Recovery after Surgery (ERAS) Program for Radical Cystectomy Patients is Associated With Decreased Postoperative Inpatient Opioid Usage and Pain Scores.
|
Academic Article
|
A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry.
|
Academic Article
|
Comparison of venous thromboembolic complications following urological surgery between patients with or without cancer.
|
Academic Article
|
High aurora kinase expression identifies patients with muscle-invasive bladder cancer who have poor survival after neoadjuvant chemotherapy.
|
Academic Article
|
Sex specific associations in genome wide association analysis of renal cell carcinoma.
|
Academic Article
|
Discordance of high PD-L1 expression in primary and metastatic urothelial carcinoma lesions.
|
Academic Article
|
The influence of obesity-related factors in the etiology of renal cell carcinoma-A mendelian randomization study.
|
Academic Article
|
Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD-SIU joint consultation on bladder cancer.
|
Academic Article
|
Use of venous-thrombotic-embolic prophylaxis in patients undergoing surgery for renal tumors: a questionnaire survey in the Nordic countries (The NORENCA-2 study).
|
Academic Article
|
MAGI2 is an independent predictor of biochemical recurrence in prostate cancer.
|
Academic Article
|
Pharmacologic Inhibition of ß-Catenin With Pyrvinium Inhibits Murine and Human Models of Wilms Tumor.
|
Academic Article
|
Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma.
|
Academic Article
|
Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.
|
Academic Article
|
Renal Mass and Localized Renal Cancer: AUA Guideline.
|
Academic Article
|
Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry.
|
Academic Article
|
Genome-wide association study identifies multiple risk loci for renal cell carcinoma.
|
Academic Article
|
Core Needle Biopsy and Fine Needle Aspiration Alone or in Combination: Diagnostic Accuracy and Impact on Management of Renal Masses.
|
Academic Article
|
TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma.
|
Academic Article
|
Functional KRAS mutations and a potential role for PI3K/AKT activation in Wilms tumors.
|
Academic Article
|
On a FOX hunt: functions of FOX transcriptional regulators in bladder cancer.
|
Academic Article
|
Shed urinary ALCAM is an independent prognostic biomarker of three-year overall survival after cystectomy in patients with bladder cancer.
|
Academic Article
|
NCCN Guidelines Insights: Bladder Cancer, Version 2.2016.
|
Academic Article
|
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline.
|
Academic Article
|
Oncologic Outcomes after Anterior Exenteration for Muscle Invasive Bladder Cancer in Women.
|
Academic Article
|
National Comprehensive Cancer Network Recommendations on Molecular Profiling of Advanced Bladder Cancer.
|
Academic Article
|
MAGI-2 Is a Sensitive and Specific Marker of Prostatic Adenocarcinoma: ?A Comparison With AMACR.
|
Academic Article
|
NF-?B and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance.
|
Academic Article
|
MAGI-2 in prostate cancer: an immunohistochemical study.
|
Academic Article
|
Natural biology and management of nonmuscle invasive bladder cancer.
|
Academic Article
|
Short term complications from transurethral resection of bladder tumor.
|
Academic Article
|
NF-?B and androgen receptor variant expression correlate with human BPH progression.
|
Academic Article
|
Nfib Regulates Transcriptional Networks That Control the Development of Prostatic Hyperplasia.
|
Academic Article
|
Renal cell cancer histological subtype distribution differs by race and sex.
|
Academic Article
|
Trends in kidney cancer among the elderly in Denmark, 1980-2012.
|
Academic Article
|
Urinary oncofetal ED-A fibronectin correlates with poor prognosis in patients with bladder cancer.
|
Academic Article
|
Toward Personalized Guidelines in Bladder Cancer.
|
Academic Article
|
A Murine Model of K-RAS and ß-Catenin Induced Renal Tumors Expresses High Levels of E2F1 and Resembles Human Wilms Tumor.
|
Academic Article
|
Genetic and chromosomal alterations in Kenyan Wilms Tumor.
|
Academic Article
|
Novel Simulation Model of Non-Muscle Invasive Bladder Cancer: A Platform for a Virtual Randomized Trial of Conservative Therapy vs. Cystectomy in BCG Refractory Patients.
|
Academic Article
|
Urothelial carcinoma with squamous differentiation: response to chemotherapy and radiation.
|
Academic Article
|
Hypoalbuminaemia is associated with mortality in patients undergoing cytoreductive nephrectomy.
|
Academic Article
|
Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder Cancer.
|
Academic Article
|
Management of noninvasive bladder cancers.
|
Academic Article
|
Lack of P16ink4a over expression in penile squamous cell carcinoma is associated with recurrence after lymph node dissection.
|
Academic Article
|
Statin use is associated with improved survival in patients undergoing surgery for renal cell carcinoma.
|
Academic Article
|
Impact of complications and hospital-free days on health related quality of life 1 year after radical cystectomy.
|
Academic Article
|
Progress made in the use of animal models for the study of high-risk, nonmuscle invasive bladder cancer.
|
Academic Article
|
Biochemical recurrence-free survival after robotic-assisted laparoscopic vs open radical prostatectomy for intermediate- and high-risk prostate cancer.
|
Academic Article
|
Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy.
|
Academic Article
|
NF-?B gene signature predicts prostate cancer progression.
|
Academic Article
|
Developments and controversies in the management of noninvasive bladder cancer.
|
Academic Article
|
Blood loss associated with radical cystectomy: a prospective, randomized study comparing Impact LigaSure vs. stapling device.
|
Academic Article
|
T1 high-grade bladder cancer recurring after BCG therapy: radical cystectomy is still the best approach. Pro.
|
Academic Article
|
Comprehensive handbook for developing a bladder cancer cystectomy database.
|
Academic Article
|
When urothelial differentiation pathways go wrong: implications for bladder cancer development and progression.
|
Academic Article
|
The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for bladder cancer.
|
Academic Article
|
Current concepts in penile cancer.
|
Academic Article
|
Penile cancer: Clinical Practice Guidelines in Oncology.
|
Academic Article
|
Restaging transurethral resection for non-muscle invasive bladder cancer: who, why, when, and how?
|
Academic Article
|
Management of superficial and muscle-invasive urothelial cancers of the bladder.
|
Academic Article
|
Bladder cancer.
|
Academic Article
|
Imaging the clear cell renal cell carcinoma proteome.
|
Academic Article
|
Anatomic basis for lymph node counts as measure of lymph node dissection extent: a cadaveric study.
|
Academic Article
|
Salvage robotic assisted laparoscopic radical prostatectomy: a single institution, 5-year experience.
|
Academic Article
|
ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markers.
|
Academic Article
|
Volume outcomes of cystectomy--is it the surgeon or the setting?
|
Academic Article
|
ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma.
|
Academic Article
|
Lymph node yield at radical cystectomy predicts mortality in node-negative and not node-positive patients.
|
Academic Article
|
Voiding function in women with orthotopic neobladder urinary diversion.
|
Academic Article
|
Tumour size, tumour complexity, and surgical approach are associated with nephrectomy type in small renal cortical tumours treated electively.
|
Academic Article
|
Multimodal therapies for muscle-invasive urothelial carcinoma of the bladder.
|
Academic Article
|
National trends in the use of partial nephrectomy: a rising tide that has not lifted all boats.
|
Academic Article
|
Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation.
|
Academic Article
|
Prostate size as a predictor of Gleason score upgrading in patients with low risk prostate cancer.
|
Academic Article
|
ß-Catenin and K-RAS synergize to form primitive renal epithelial tumors with features of epithelial Wilms' tumors.
|
Academic Article
|
Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomy.
|
Academic Article
|
Detection of tumor cells in the bone offers independent prognostic value in bladder cancer patients: the clinical and basic science perspective.
|
Academic Article
|
Urinary collecting system invasion is a predictor for overall and disease-specific survival in locally invasive renal cell carcinoma.
|
Academic Article
|
Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma.
|
Academic Article
|
Bladder cancer.
|
Academic Article
|
Tumor volume as a predictor of adverse pathologic features and biochemical recurrence (BCR) in radical prostatectomy specimens: a tale of two methods.
|
Academic Article
|
Serum methionine metabolites are risk factors for metastatic prostate cancer progression.
|
Academic Article
|
Effect of preoperative nutritional deficiency on mortality after radical cystectomy for bladder cancer.
|
Academic Article
|
Determining factors for hospital discharge status after radical cystectomy in a large contemporary cohort.
|
Academic Article
|
A simple, effective method to create laparoscopic renal protective hypothermia with cold saline surface irrigation: clinical application and assessment.
|
Academic Article
|
Early and late perioperative outcomes following radical cystectomy: 90-day readmissions, morbidity and mortality in a contemporary series.
|
Academic Article
|
Comparative analysis of whole mount processing and systematic sampling of radical prostatectomy specimens: pathological outcomes and risk of biochemical recurrence.
|
Academic Article
|
Comparison of transfusion requirements between open and robotic-assisted laparoscopic radical prostatectomy.
|
Academic Article
|
TRAIL and interferon-alpha act synergistically to induce renal cell carcinoma apoptosis.
|
Academic Article
|
Smaller prostate size predicts high grade prostate cancer at final pathology.
|
Academic Article
|
Preoperative hydronephrosis predicts extravesical and node positive disease in patients undergoing cystectomy for bladder cancer.
|
Academic Article
|
Bladder cancer.
|
Academic Article
|
Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology.
|
Academic Article
|
Robotic assisted laparoscopic prostatectomy versus radical retropubic prostatectomy for clinically localized prostate cancer: comparison of short-term biochemical recurrence-free survival.
|
Academic Article
|
Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology.
|
Academic Article
|
Impact of positive apical surgical margins on likelihood of biochemical recurrence after radical prostatectomy.
|
Academic Article
|
Pathological stage T2 subgroups to predict biochemical recurrence after prostatectomy.
|
Academic Article
|
Urinary diversion trends at a high volume, single American tertiary care center.
|
Academic Article
|
The role of VHL in clear-cell renal cell carcinoma and its relation to targeted therapy.
|
Academic Article
|
Outcomes of patients undergoing radical cystoprostatectomy for bladder cancer with prostatic involvement on final pathology.
|
Academic Article
|
Risk factors for urothelial carcinoma of the prostate in patients undergoing radical cystoprostatectomy for bladder cancer.
|
Academic Article
|
Cytokine genetic polymorphisms and prostate cancer aggressiveness.
|
Academic Article
|
Neoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer.
|
Academic Article
|
Radical nephrectomy surgical outcomes in the University HealthSystem Consortium Data Base: Impact of hospital case volume, hospital size, and geographic location on 40,000 patients.
|
Academic Article
|
Editorial comment on: Vaccine therapy in patients with renal cell carcinoma.
|
Academic Article
|
Bladder cancer.
|
Academic Article
|
Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
|
Academic Article
|
Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
|
Academic Article
|
Prognostic factors in T3b renal cell carcinoma.
|
Academic Article
|
Intake of plant foods and associated nutrients in prostate cancer risk.
|
Academic Article
|
Bladder cancer.
|
Academic Article
|
Chemokine markers predict biochemical recurrence of prostate cancer following prostatectomy.
|
Academic Article
|
The von Hippel-Lindau gene: turning discovery into therapy.
|
Academic Article
|
Renal peripheral neuroectodermal tumor presenting at age 78: case report.
|
Academic Article
|
Waiting time from initial urological consultation to nephrectomy for renal cell carcinoma--does it affect survival?
|
Academic Article
|
Effect of a large prostate gland on open and robotically assisted laparoscopic radical prostatectomy.
|
Academic Article
|
Bladder cancer.
|
Academic Article
|
Interactions of cytokine gene polymorphisms in prostate cancer risk.
|
Academic Article
|
A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy.
|
Academic Article
|
Upper tract transitional cell carcinoma: finding a way forward.
|
Academic Article
|
Association of procedure volume with radical cystectomy outcomes in a nationwide database.
|
Academic Article
|
Tumor-derived mutations in the TRAIL receptor DR5 inhibit TRAIL signaling through the DR4 receptor by competing for ligand binding.
|
Academic Article
|
Recent advances in targeted therapy for renal cell carcinoma.
|
Academic Article
|
Does a delay in initiating definitive therapy affect biochemical recurrence rates in men with clinically localized prostate cancer?
|
Academic Article
|
Bladder cancer.
|
Academic Article
|
Vinorelbine, doxorubicin, and prednisone in androgen-independent prostate cancer.
|
Academic Article
|
Complementary and alternative medicine for advanced prostate cancer.
|
Academic Article
|
Bladder cancer.
|
Academic Article
|
Percentage of positive biopsies associated with freedom from biochemical recurrence after low-dose-rate prostate brachytherapy alone for clinically localized prostate cancer.
|
Academic Article
|
Recent advances in the treatment of bladder cancer.
|
Academic Article
|
Inflammatory myofibroblastic tumor associated with renal cell carcinoma.
|
Academic Article
|
Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
|
Academic Article
|
Radical cystectomy in the elderly: comparison of clincal outcomes between younger and older patients.
|
Academic Article
|
Contemporary management of the urethra in patients after radical cystectomy for bladder cancer.
|
Academic Article
|
Bladder cancer.
|
Academic Article
|
Radical cystectomy in the elderly: Comparison of survival between younger and older patients.
|
Academic Article
|
A rare case of an extra-adrenal myelolipoma arising in the renal sinus: a case report and review of the literature.
|
Academic Article
|
The management of urethral transitional cell carcinoma after radical cystectomy for invasive bladder cancer.
|
Academic Article
|
Utility of frozen section analysis of resection margins during partial nephrectomy.
|
Academic Article
|
Endourologic management of upper tract transitional cell carcinoma.
|
Academic Article
|
Bladder cancer.
|
Academic Article
|
Microscopic and gross extravesical extension in pathological staging of bladder cancer.
|
Academic Article
|
Prostate cancer and bone metastases: medical treatment.
|
Academic Article
|
Natural history of surgically treated bladder carcinoma with extravesical tumor extension.
|
Academic Article
|
Bladder cancer.
|
Academic Article
|
The androgen receptor CAG repeat and prostate cancer risk.
|
Academic Article
|
Androgen receptor activity at the prostate specific antigen locus: steroidal and non-steroidal mechanisms.
|
Academic Article
|
Angiomyolipoma with vena caval extension.
|
Academic Article
|
Urinary diversion after radical cystectomy.
|
Academic Article
|
Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer.
|
Academic Article
|
Quality of life and psychological adaptation after surgical treatment for localized renal cell carcinoma: impact of the amount of remaining renal tissue.
|
Academic Article
|
Exophytic noninvasive growth pattern of renal angiomyolipomas: implications for nephron sparing surgery.
|
Academic Article
|
Surgery for invasive bladder tumors: technique and outcome.
|
Academic Article
|
Renal cell carcinoma-derived gangliosides suppress nuclear factor-kappaB activation in T cells.
|
Academic Article
|
Mechanisms of apoptosis in T cells from patients with renal cell carcinoma.
|
Academic Article
|
Alterations in NFkappaB activation in T lymphocytes of patients with renal cell carcinoma.
|
Academic Article
|
13-year experience with percutaneous management of upper tract transitional cell carcinoma.
|
Academic Article
|
A review of scrotal violation in testicular cancer: is adjuvant local therapy necessary?
|